Dr. Reddy's Laboratories Limited (BOM:500124)
India · Delayed Price · Currency is INR 1,200.10
-35.90 (-2.90%)
At close: Oct 1, 2026
Dr. Reddy's Laboratories Market Cap
Dr. Reddy's Laboratories has a market cap or net worth of 999.66 billion as of October 2, 2026. Its market cap has decreased by -1.86% in one year.
Market Cap
999.66B
Enterprise Value
993.50B
Revenue
331.19B
Ranking
n/a
PE Ratio
30.21
Stock Price
1,200.10
ChartMarket Cap Chart
Since May 31, 1999, Dr. Reddy's Laboratories's market cap has increased from 21.00B to 999.66B, an increase of 4,659.31%. That is a compound annual growth rate of 15.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 999.66B | -5.53% |
| Dec 31, 2025 | 1.06T | -8.50% |
| Dec 31, 2024 | 1.16T | 19.80% |
| Dec 29, 2023 | 965.41B | 37.28% |
| Dec 30, 2022 | 703.23B | -13.66% |
| Dec 31, 2021 | 814.50B | -5.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.81T |
| Lupin | 927.73B |
| Abbott India | 570.16B |
| GlaxoSmithKline Pharmaceuticals | 470.02B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 203.39B |
| Caplin Point Laboratories | 200.09B |
| Jubilant Pharmova | 158.49B |